Advancing clinical education in Multiple Myeloma

Register

EMN Perspective is a scientific educational initiative developed for healthcare professionals involved in the management of multiple myeloma. The programme combines live and on-demand webinars with a guided digital platform featuring an integrated AI tool, designed to support rapid consultation of curated scientific content.

Register

What's inside

1

Patients with Newly Diagnosed Multiple Myeloma

Diagnostic and therapeutic approach in patients with newly diagnosed Multiple Myeloma

Topics covered:

  • What is the standard / best choice? – P. Sonneveld
  • Maintenance – what is the best duration? – E. Zamagni
  • Future perspective frontline – E. Terpos
  • Challenging case – A. Brioli
  • Concluding discussion
Access module
2

Patients with Relapse/Refractory Multiple Myeloma

Management of early and late relapse, therapeutic sequencing strategies

Topics covered:

  • Early relapse
  • Later relapse
  • Sequencing
  • Challenging case
  • Concluding discussion
Access module
3

Adverse Events: Recognition, management, and coordination of care

Recognition and management of adverse events

Topics covered:

  • Neurotoxicity
  • Ophthalmologic – M. Gavriatopoulou
  • Skin, nails, mouth – C. Stege
  • Immune system/infections – J. Radocha
  • Challenging case – I. Ntanasis-Stathopoulos
  • Concluding discussion
Access module
4

Special scenarios

Complex clinical scenarios: EMD, PPCL, and high-risk situations

Topics covered:

  • Extramedullary disease (EMD)
  • Primary plasma cell leukemia (PPCL)
  • Functional high-risk disease
  • Challenging Case
  • Concluding discussion
Access module
5

Future innovations and AI

Artificial intelligence in hemato-oncology: clinical applications and regulatory perspectives

Topics covered:

  • Generative AI for clinicians (basic principles, capabilities and limitations, hallucinations, and how to interact safely and critically with a chatbot-based tool) – A. Mosquera
  • Applied AI in hemato-oncology (AI in medical imaging and image-derived risk biomarkers)
  • Relevant EMN projects in AI for Multiple Myeloma – A. Mosquera
  • Regulatory and clinical-trial perspectives on AI applications in Europe
  • Concluding discussion
Access module